Radiation Dosimetry in Adults
| Radiopharmaceutical | Administered activity (MBq) | Critical organ (bladder) | Effective dose |
| 99mTc-phosphates (intravenous) | 500–1,110 | 0.047 (mGy/MBq) | 0.0049 (mSv/MBq) |
| 34.8 (mGy/740 MBq) | 3.6 (mSv/740 MBq) | ||
| 52.2 (mGy/1,110 MBq) | 5.4 (mSv/1,110 MBq) |
Values for normal bone uptake and normal renal function are from Radiation Dose to Patients from Radiopharmaceuticals. London, U.K.: ICRP; 1988:215. ICRP report 53. See also Weber DA, Makler PT Jr, Watson EE, Coffey JL, Thomas SR, London J. MIRD dose estimate report no. 13: radiation absorbed dose from technetium-99m-labeled bone imaging agents. J Nucl Med. 1989;30:1117–1122.